Global Lungs in Vitro Market to reach USD 601.3 million by 2025 | CAGR: 17.7%
Global Lungs in Vitro Market is valued at USD 138.7 million in 2016 is anticipated to grow USD 601.3 million with the compounded annual growth of 17.7% over the forecast period 2017-2025.
New York 29 May 2018, As per the new research study conducted by Bizwit Research & Consulting, Global Lungs in Vitro industry is poised to raise USD 601.3 million by 2025. Focus on developing alternatives for animal testing models, advancements in 3D cell culture technology and the development of new 3D in vitro models are factors driving the growth of this market. To view the summary or to request a sample copy of this report, please click the link mentioned below:
The industry is seeming to be fairly competitive. Some of the leading market players include. ATCC, Lonza, Epithelix, Mattek, Emulate, Tissuse, Mimetas, Insphero, Cn Bio Innovations New product launches, acquisitions, and mergers are some of the strategies adopted by the key manufacturers. Additionally, the fierce competitiveness has made these players spend in product developments to improve the customer’s requirements.
Key findings of the study:
- The North America region estimated for dominating the Lungs in Vitro market during the forecast period.
- North America will be the highest growing segment with respect to geographical segmentation by around XX%
- Asia PacificLungs in Vitro market is estimated to grow at the highest CAGR during the forecast period.
Bizwit Research & Consulting LLP has considered the following segments for the study:
- 2D Cell Models
- 3D Cell Models
- Commercial 3D Cell Models
- In-house 3D Cell Models
- North America
- Asia Pacific
- Rest of the World